PortalPublikationenRisk stratification of pT1-3N0 patients after radical cystec...

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling

Standard

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling. / Xylinas, E; Cha, E K; Sun, M; Rink, M; Trinh, Q-D; Novara, G; Green, D A; Pycha, A; Fradet, Y; Daneshmand, S; Svatek, R S; Fritsche, H-M; Kassouf, W; Scherr, D S; Faison, T; Crivelli, J J; Tagawa, S T; Zerbib, M; Karakiewicz, P I; Shariat, S F.

in: BRIT J CANCER, Jahrgang 107, Nr. 11, 11, 20.11.2012, S. 1826-1832.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Xylinas, E, Cha, EK, Sun, M, Rink, M, Trinh, Q-D, Novara, G, Green, DA, Pycha, A, Fradet, Y, Daneshmand, S, Svatek, RS, Fritsche, H-M, Kassouf, W, Scherr, DS, Faison, T, Crivelli, JJ, Tagawa, ST, Zerbib, M, Karakiewicz, PI & Shariat, SF 2012, 'Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling', BRIT J CANCER, Jg. 107, Nr. 11, 11, S. 1826-1832. https://doi.org/10.1038/bjc.2012.464

APA

Xylinas, E., Cha, E. K., Sun, M., Rink, M., Trinh, Q-D., Novara, G., Green, D. A., Pycha, A., Fradet, Y., Daneshmand, S., Svatek, R. S., Fritsche, H-M., Kassouf, W., Scherr, D. S., Faison, T., Crivelli, J. J., Tagawa, S. T., Zerbib, M., Karakiewicz, P. I., & Shariat, S. F. (2012). Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling. BRIT J CANCER, 107(11), 1826-1832. [11]. https://doi.org/10.1038/bjc.2012.464

Vancouver

Xylinas E, Cha EK, Sun M, Rink M, Trinh Q-D, Novara G et al. Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling. BRIT J CANCER. 2012 Nov 20;107(11):1826-1832. 11. https://doi.org/10.1038/bjc.2012.464

Bibtex

@article{389fd726f1374120b79e28104f2553a2,
title = "Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling",
abstract = "In pT1-T3N0 urothelial carcinoma of the bladder (UCB) patients, multi-modal therapy is inconsistently recommended. The aim of the study was to develop a prognostic tool to help decision-making regarding adjuvant therapy.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Cohort Studies, Europe, Reproducibility of Results, Follow-Up Studies, Combined Modality Therapy, Proportional Hazards Models, United States, Neoplasm Staging, Chemotherapy, Adjuvant, *Cystectomy, Counseling, Neoplasm Recurrence, Local/etiology, Urinary Bladder Neoplasms/mortality/pathology/*therapy, Adult, Humans, Male, Aged, Female, Middle Aged, Aged, 80 and over, Cohort Studies, Europe, Reproducibility of Results, Follow-Up Studies, Combined Modality Therapy, Proportional Hazards Models, United States, Neoplasm Staging, Chemotherapy, Adjuvant, *Cystectomy, Counseling, Neoplasm Recurrence, Local/etiology, Urinary Bladder Neoplasms/mortality/pathology/*therapy",
author = "E Xylinas and Cha, {E K} and M Sun and M Rink and Q-D Trinh and G Novara and Green, {D A} and A Pycha and Y Fradet and S Daneshmand and Svatek, {R S} and H-M Fritsche and W Kassouf and Scherr, {D S} and T Faison and Crivelli, {J J} and Tagawa, {S T} and M Zerbib and Karakiewicz, {P I} and Shariat, {S F}",
year = "2012",
month = nov,
day = "20",
doi = "10.1038/bjc.2012.464",
language = "English",
volume = "107",
pages = "1826--1832",
journal = "BRIT J CANCER",
issn = "0007-0920",
publisher = "NATURE PUBLISHING GROUP",
number = "11",

}

RIS

TY - JOUR

T1 - Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling

AU - Xylinas, E

AU - Cha, E K

AU - Sun, M

AU - Rink, M

AU - Trinh, Q-D

AU - Novara, G

AU - Green, D A

AU - Pycha, A

AU - Fradet, Y

AU - Daneshmand, S

AU - Svatek, R S

AU - Fritsche, H-M

AU - Kassouf, W

AU - Scherr, D S

AU - Faison, T

AU - Crivelli, J J

AU - Tagawa, S T

AU - Zerbib, M

AU - Karakiewicz, P I

AU - Shariat, S F

PY - 2012/11/20

Y1 - 2012/11/20

N2 - In pT1-T3N0 urothelial carcinoma of the bladder (UCB) patients, multi-modal therapy is inconsistently recommended. The aim of the study was to develop a prognostic tool to help decision-making regarding adjuvant therapy.

AB - In pT1-T3N0 urothelial carcinoma of the bladder (UCB) patients, multi-modal therapy is inconsistently recommended. The aim of the study was to develop a prognostic tool to help decision-making regarding adjuvant therapy.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Cohort Studies

KW - Europe

KW - Reproducibility of Results

KW - Follow-Up Studies

KW - Combined Modality Therapy

KW - Proportional Hazards Models

KW - United States

KW - Neoplasm Staging

KW - Chemotherapy, Adjuvant

KW - Cystectomy

KW - Counseling

KW - Neoplasm Recurrence, Local/etiology

KW - Urinary Bladder Neoplasms/mortality/pathology/therapy

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Aged, 80 and over

KW - Cohort Studies

KW - Europe

KW - Reproducibility of Results

KW - Follow-Up Studies

KW - Combined Modality Therapy

KW - Proportional Hazards Models

KW - United States

KW - Neoplasm Staging

KW - Chemotherapy, Adjuvant

KW - Cystectomy

KW - Counseling

KW - Neoplasm Recurrence, Local/etiology

KW - Urinary Bladder Neoplasms/mortality/pathology/therapy

U2 - 10.1038/bjc.2012.464

DO - 10.1038/bjc.2012.464

M3 - SCORING: Journal article

C2 - 23169335

VL - 107

SP - 1826

EP - 1832

JO - BRIT J CANCER

JF - BRIT J CANCER

SN - 0007-0920

IS - 11

M1 - 11

ER -